Etoposide/irinotecanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24995-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：259 / 259

相关论文

共 50 条

[41] Etoposide/ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 199 - 199
[42] Cisplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 197 - 197
[43] Carboplatin/etoposide/temozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 134 - 134
[44] Cisplatin/etoposide/tolvaptanLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 156 - 156
[45] Etoposide/plasma/unspecified steroidsLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 222 - 222
[46] Carboplatin/etoposide/toripalimabLack of efficacy and hypophysitis: case report
Reactions Weekly, 2023, 1957 (1) : 119 - 119
[47] Dexamethasone/Etoposide/Immune globulinLack of efficacy: case report
Reactions Weekly, 2024, 2023 (1) : 136 - 136
[48] Dexamethasone/etoposide/tocilizumabLack-of-efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 192 - 192
[49] Cisplatin/etoposide/pembrolizumabLack of efficacy and hypophysitis: case report
Reactions Weekly, 2023, 1977 (1) : 101 - 101
[50] Cisplatin/doxorubicin/etoposide/mitotaneLack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 175 - 175

← 1 2 3 4 5 →